Dyne Therapeutics (NASDAQ:DYN) Price Target Raised to $48.00
Dyne Therapeutics (NASDAQ:DYN – Free Report) had its target price hoisted by HC Wainwright from $36.00 to $48.00 in a research note released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ FY2025 earnings at ($1.41) EPS, FY2026 earnings at $0.23 EPS, […]
More Stories
Brighthouse Financial, Inc. (NASDAQ:BHFAP) Sees Significant Increase in Short Interest
Brighthouse Financial, Inc. (NASDAQ:BHFAP – Get Free Report) was the target of a significant growth in short interest in September....
US Strikes Kill 37 ISIS Operatives, Terrorists in Syria
By Jackson Richman The United States killed 37 terrorist group members, including leaders tied to ISIS and Al Qaeda affiliate...
BlackRock High Yield ETF (NASDAQ:BRHY) Short Interest Down 27.3% in September
BlackRock High Yield ETF (NASDAQ:BRHY – Get Free Report) was the target of a significant decrease in short interest during...
Federal Major Disaster Declared for North Carolina, Florida After Helene
By Jack Phillips President Joe Biden on Sunday approved a federal major disaster in North Carolina and Florida after storm...
ICE: Over 425,000 Criminal Illegal Immigrants Not in Agency’s Custody, Including 13,099 Convicted Killers
By Tom Ozimek Federal immigration authorities have revealed that more than 425,000 illegal immigrants convicted of crimes, including more than...
Short Interest in Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna (OTCMKTS:PSZKY) Rises By 40.0%
Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna (OTCMKTS:PSZKY – Get Free Report) was the recipient of a significant growth in...